Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2024 08:15 ET | Source: HeartFlow Holding, Inc.

Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024

— Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease -– FFRCT further...
October 14, 2024 08:00 ET | Source: HeartFlow Holding, Inc.

HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024

Long-term outcomes data from ADVANCE-DK Registry with HeartFlow FFRCT and Plaque Analysis and ongoing clinical studies highlighting CCTA and FFRCT diagnostic pathway to be discussed in six...
October 25, 2023 11:00 ET | Source: HeartFlow Holding, Inc.

TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights

New Clinical Data Support Use of Lesion-Specific FFRCT for Diagnosis and Treatment of Patients With Coronary Artery Disease
March 10, 2022 11:05 ET | Source: Rackspace Technology, Inc.

Rackspace Technology Launches Technical Career Track Program

SAN ANTONIO, March 10, 2022 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company, today announced a revitalized Technical Career...
September 16, 2014 09:00 ET | Source: Amaranth Medical, Inc.

Amaranth Medical Initiates Clinical Trial of the Second-Generation FORTITUDE Bioresorbable Drug-Eluting Scaffold

MOUNTAIN VIEW, CA, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced the initiation of patient enrollment in multiple centers in Colombia, South...
September 10, 2014 09:29 ET | Source: The Spectranetics Corporation

Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C.

COLORADO SPRINGS, Colo., Sept. 10, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that data from EXCITE ISR will be presented as a late-breaking clinical trial at...
October 24, 2013 08:00 ET | Source: Colibri Heart Valve LLC

Colibri Heart Valve Concludes Patient Enrollment in First-in-Human Study of Proprietary TAVI System in Dominican Republic

BROOMFIELD, CO, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held medical device company, announced that patient enrollment has concluded in the first-in-human study of...